Device companies watch US Supreme Court case on pre-emption
This article was originally published in Clinica
Executive Summary
The US Supreme Court may devise a narrowly tailored ruling in a pharmaceutical case in addressing the question of whether state-based product liability claims can be federally pre-empted.